Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A machine learning approach for understanding the metabolomics response of children with autism spectrum disorder to medical cannabis treatment

22 Aug 2023

Abstract excerpt

Autism spectrum disorder (ASD) is a neurodevelopmental condition impacting behavior, communication, social interaction and learning abilities. Medical cannabis (MC) treatment can reduce clinical symptoms in individuals with ASD. Cannabis-responsive biomarkers are metabolites found in saliva that change in response to MC treatment. Previously we showed levels of these biomarkers in children with ASD successfully...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cannabis and Cannabinoid Research
Share to GABA and Rice Research
Share to Pancreatic function and diabetes

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37608004
DOI: 10.1038/s41598-023-40073-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 10 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A machine learning approach for understanding the metabolomics response of children with autism spectrum disorder to medical cannabis treatmentPMID 37608004Read ↗

Metabolomics: Perspectives on Clinical Employment in Autism Spectrum Disorder.Semantic proximity Read ↗

A Subset of Patients With Autism Spectrum Disorders Show a Distinctive Metabolic Profile by Dried Blood Spot AnalysesSemantic proximity Read ↗

Translational Study of using FOCM/TS Metabolites for Supporting Autism Spectrum Disorder DiagnosisSemantic proximity Read ↗

Proteomics and Metabolomics Approaches towards a Functional Insight onto AUTISM Spectrum Disorders: Phenotype Stratification and Biomarker Discovery.Semantic proximity Read ↗

Safety and efficacy of orally administered full-spectrum medicinal cannabis plant extract 0.08% THC (NTI-164) in children with autism spectrum disorder: An open-label studySemantic proximity Read ↗

Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions.Semantic proximity Read ↗

Reproducible Biochemical Modes Within a Structured Neurochemical Continuum in Autism Spectrum Disorder Revealed by NeuroCLADSemantic proximity Read ↗

Metabolomics of autism spectrum disorders: early insights regarding mammalian-microbial cometabolites.Semantic proximity Read ↗

Untargeted metabolomic study of autism in newborn screening samples: a pilot studySemantic proximity Read ↗

Phenotypically driven subgroups of ASD display distinct metabolomic profiles.Semantic proximity Read ↗

Cannabinoids for People with ASD: A Systematic Review of Published and Ongoing StudiesSemantic proximity Read ↗

Elevated Microbially-Derived Metabolites in Autism: A Possible Diagnostic Screening Test for a Distinct ASD PhenotypeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.